01.12.2017 | Study protocol | Ausgabe 1/2017 Open Access

Internet-based perioperative exercise program in patients with Barrett’s carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trial
- Zeitschrift:
- BMC Cancer > Ausgabe 1/2017
Background
Methods/Study design
#
|
Inclusion criteria
|
---|---|
1.
|
Histologically proven adenocarcinoma of the esophagus or adenocarcinoma of the esophagogastric junction type I-II according to Siewert’s classification, clinical stages IIB-IIIC (T3/T4 and/or N+; M0) according to UICC, 7th edition
|
2.
|
Male
|
3.
|
Age between 18 and 75 years
|
4.
|
Resectable stage according to discussion in the local multidisciplinary tumor board (MDT) of the participating centers and patient medically fit for multimodality therapy (ECOG performance status at least 1 or better, no severe impairment of cardiac, renal, hepatic, endocrine, bone marrow and cerebral functions)
|
5.
|
Planned abdomino-thoracic esophagectomy with gastric pull-up and intrathoracic or cervical anastomosis
|
6.
|
#
|
Exclusion criteria
|
---|---|
1.
|
Presence of a second malignant tumor (unless curatively treated >5 years ago)
|
2.
|
Chemotherapy or radiochemotherapy in patient’s history
|
3.
|
Orthopedic, rheumatologic, cardiovascular or neurologic (epilepsy, stroke, Parkinson’s disease, muscle wasting diseases such as amyotrophic lateral sclerosis or multiple sclerosis) contraindications for the exercise program
|
4.
|
Inability to use the internet or no internet access
|
5.
|
Inability to communicate in German
|
6.
|
Each active disease, which hinders completion of the study
|
7.
|
Active alcoholism or illegal drug consumption within the last six months before study entry
|
-
Change in VO 2peak at 12 weeks after surgery
-
Change in Forced Expiratory Volume in 1 s (FEV1) directly prior to surgery and at 12 weeks after surgery
-
Change in Forced Vital Capacity (FVC) directly prior to surgery and at 12 weeks after surgery
Sample-size calculation and statistical analyzes
Intervention
Stage
|
Speed (kilometers/hour)
|
Angle of inclination (degree)
|
Duration (minutes)
|
---|---|---|---|
1
|
3
|
1.5
|
3
|
2
|
3.7
|
3.0
|
3
|
3
|
4.4
|
4.9
|
3
|
4
|
5.1
|
6.3
|
3
|
5
|
5.8
|
7.4
|
3
|
6
|
6.5
|
8.2
|
3
|
7
|
6.5
|
9.8
|
3
|
8
|
6.5
|
11.4
|
3
|
9
|
6.5
|
13.0
|
3
|
10
|
6.5
|
14.6
|
3
|
11
|
6.5
|
16.2
|
3
|
12
|
6.5
|
17.8
|
3
|
13
|
6.5
|
19.4
|
3
|
14
|
6.5
|
21.0
|
3
|
Absolute indication
|
Relative indication
|
---|---|
ECG ST-segment depression ≥3 mm
|
Hypertensive dysregulation (RR
syst 230–260 mmHg, RR
diast ≥ 115 mmHg)
|
ECG ST-segment elevation ≥1 mm
|
Drop in blood pressure > 10 mmHg (compared to baseline blood pressure) without signs of myocardial ischemia (no angina pectoris, no ECG ST-segment depression)
|
Drop in blood pressure > 10 mmHg (compared to baseline blood pressure) with signs of myocardial ischemia (angina pectoris, ECG ST-segment depression)
|
Polymorphic extrasystols, duplets (2 consecutive ventricular extrasystols), salves (≥ 3 consecutive ventricular extrasystols)
|
Moderate-severe angina pectoris-symptoms
|
Supraventricular tachycardias
|
Severe dyspnea
|
Bradyarrhythmias
|
Clinical signs of less perfusion (cyanosis)
|
Line faults
|
Persistent (duration >30 s) ventricular tachycardias
|
Presence of line faults (high AV-blockage, branch block)
|
Exhaustion of the patient
|
reinforced angina pectoris symptoms
|
Technical problems (defect ECG-registration, monitor failure)
|